Clinical Trials

NCT06126276 | RECRUITING | PHASE2
70 participants

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2024-05-07
Completion:
2027-02-20
Conditions
  • Malignant Female Reproductive System Neoplasm
  • Malignant Solid Neoplasm
  • Recurrent Malignant Female Reproductive System Neoplasm
  • Recurrent Malignant Solid Neoplasm
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT06103838 | RECRUITING | PHASE2
60 participants

18F-Fluciclovine PET/CT in Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2024-03-25
Completion:
2027-12-06
Conditions
  • Multiple Myeloma
  • Newly Diagnosed Multiple Myeloma (NDMM)
  • Relapsed and/or Refractory Multiple Myeloma (RRMM)
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05985655 | RECRUITING | PHASE1/PHASE2
230 participants

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2023-07-06
Completion:
2028-01-31
Conditions
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pancreatic Adenocarcinoma
  • Non-small Cell Lung Cancer (NSCLC)
  • Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)
  • Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma
  • Triple Negative Breast Cancer (TNBC)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page